Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases

计划入组 700 人 · 首次发布于 2025 年 5 月 21 日

Surgical Positions and Postoperative Atelectasis: A Lung Ultrasound Study

计划入组 100 人 · 首次发布于 2026 年 6 月 17 日

Leveraging the Emergency Department (LEAD) Study

计划入组 100 人 · 首次发布于 2024 年 9 月 20 日

Tergenpumatucel-L

Bria-Lung

Lung-H1

Lung Therapeutics, Inc.

United States

Sec Lung, LLC

United States

Lung Healing Technologies Inc

United States

AstraZeneca and Daiichi Sankyo Seek FDA Approval for Datopotamab Deruxtecan in EGFR-Mutated NSCLC

Kelun's TROP2-Targeted ADC Shows Promise in First-Line Lung Cancer Trial

Phase 3 Trials Launched to Evaluate Datopotamab Deruxtecan Combinations in Advanced NSCLC